Baird analyst Brian Skorney said he was incrementally positive on new data from Biohaven Pharmaceutical Holding (NYSE: BHVN). The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE